|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 05768245.2 (espacenet) (Federated) (European Patent Register), 20050330 | | Patent/reg. no. and date | DK/EP 1734997, 20150902 | | Publication date | 20061227 | | Priority no. and date | US 558120 P, 20040401 | | EP pub. no. and date |
EP 1734997 20061227 | | Effective date | | | Applicant/owner | Biogen MA Inc., 250 Binney Street Cambridge
Massachusetts 02142, US | | Applicant ref. no. | P21753DKEP | | Inventor | LIEBERBURG, Ivan, 85 Hillcrest Road
Berkeley, California 94705, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 1/00 (2006.01) , A61P 11/06 (2006.01) , A61P 37/00 (2006.01) | | Title | Natalizumab til anvendelse ved behandling af sygdomme med behov for steroidbehandling | | Int. application no. | US2005010848 | | Int. publication no. | WO2005099776 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
